FDA Calls GSK's Avandia Safe Amid Public Concerns

Law360, New York (February 23, 2010, 2:13 PM EST) -- On the heels of senators blasting the U.S. Food and Drug Administration for its purportedly lax regulation of the GlaxoSmithKline PLC drug Avandia, the agency has published a safety announcement telling consumers they should not stop taking the diabetes medication.

The agency, which issued the announcement Monday, said it was still reviewing data from a large, long-term clinical study on possible cardiovascular risks associated with rosiglitazone — the primary component of Avandia used to treat type 2 diabetes mellitus — and will not make any new...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.